Skip to content

Evonik Industries
Search Search

Skip over generic navigation

  • www.evonik.com

Skip over primary navigation

EUDRAGIT® | HOMEEUDRAGIT® | HOME
  • About EUDRAGIT®About EUDRAGIT®
  • Products & servicesProducts & services
  • Workshops & eventsWorkshops & events
  • DownloadsDownloads
  • e-Labe-Lab
  • ContactContact

Skip over visual

Skip over functional column



Skip over functional column

EUDRAGIT® - Functional polymers for protective, enteric and sustained-release formulations

  • Products & services
  • EUDRAGIT® products
  • Protective formulations
  • EUDRAGIT® E PO

EUDRAGIT® E PO

EUDRAGIT® E PO is a cationic copolymer based on dimethylaminoethyl methacrylate, butyl methacrylate, and methyl methacrylate. 

Physical properties: It is a white powder with a characteristic amine-like odour.

Chemical structure:

 

 

 

 

 

 

 

Product Form: Powder
Targeted Drug Release Area: Stomach
Dissolution:

  • Soluble in gastric fluid up to pH 5.0
  • Swellable and permeable above pH 5.0

 

Characteristics:

  • Low viscosity, high pigment binding capacity, good adhesion
  • low polymer weight gain

 

CAS number: 24938 – 16 – 7
Chemical/IUPAC name: Poly(butyl methacylate-co-(2-dimethylaminoethyl) methacrylate-co-methyl methacrylate) 1:2:1
INCI name: Acrylates / Dimethylaminoethyl Methacrylate Copolymer 


Monographs:

       Ph. Eur.: Basic Butylated Methacrylate Copolymer
       USP/NF: polymer conforms to Amino Methacrylate Copolymer - NF 
      JPE: Aminoalkyl Methacrylate Copolymer E

GMP standard: The Joint IPEC – PQG Good Manufacturing Practice
Guide for Bulk Pharmaceutical Excipients 2006 and
USP-NF General Chapter <1078>

Drug Master file: #1242
Weight average molar mass: approx. 47,000 g/mol 
Alkali Value: 180 mg KOH/ g polymer
Glass Transition Temperature (Tg): ~48°C

An according EIP format is available on request.

Quickstarts
  • EUDRAGIT® E PO - Protective Coating with Talc as Anti-Tacking Agent
  • EUDRAGIT® E PO - ReadyMix Protective Coating
Pharmacopoeial Monographs

more

Other Protective Formulations
  • EUDRAGIT® E 100
  • EUDRAGIT® E 12,5
 

Overview

Business model
News

Overview

EUDRAGIT® products
  • Enteric formulations
    • EUDRAGIT® L 30 D-55
    • EUDRAGIT® L 100-55
    • EUDRAGIT® L 100
    • EUDRAGIT® L 12,5
    • EUDRAGIT® S 100
    • EUDRAGIT® S 12,5
    • EUDRAGIT® FS 30 D
  • Protective formulations
    • EUDRAGIT® E 100
    • EUDRAGIT® E 12,5
    • EUDRAGIT® E PO
  • Sustained-release formulations
    • EUDRAGIT® RL 100
    • EUDRAGIT® RL PO
    • EUDRAGIT® RL 30 D
    • EUDRAGIT® RL 12,5
    • EUDRAGIT® RS 100
    • EUDRAGIT® RS PO
    • EUDRAGIT® RS 30 D
    • EUDRAGIT® RS 12,5
    • EUDRAGIT® NE 30 D
    • EUDRAGIT® NE 40 D
    • EUDRAGIT® NM 30 D
  • PlasACRYL™ T20
Technical support
  • Laboratories worldwide
    • Laboratories in China
    • Laboratories in Germany
    • Laboratories in India
    • Laboratories in Japan
    • Laboratories in the USA
Formulation development
GMP services
  • GMP facilities in Germany
Proof of concept
Advanced drug delivery

Overview

Workshops
Trade shows
Webinars

Overview

Pharma Polymers News
EUDRAGIT® Quickstarts
Brochures
Scientific posters
Product specifications
Other downloads

Overview

Open the e-Lab
What is the e-Lab?
 
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page